Angelo Scopelianos Axogen, Inc. (AXGN) insider trading activity

Angelo Scopelianos is Chief R&D Officer of Axogen, Inc.. Currently has a direct ownership of 57,994 shares of AXGN, which is worth approximately $773,639. The most recent transaction as insider was on Mar 21, 2024, when has been sold 6,881 shares (Common Stock) at a price of $7.68 per share, resulting in proceeds of $52,846. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 58K

0% 3M change

56.87% 12M change

Total Value Held $773,639

Angelo Scopelianos Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 21 2024	SELL Open market or private sale	$52,846 $7.68 p/Share	6,881 Reduced 10.61%	57,994 Common Stock
Mar 21 2024	BUY Exercise of conversion of derivative security	-	2,500 Added 4.09%	58,604 Common Stock
Mar 16 2024	BUY Exercise of conversion of derivative security	-	25,406 Added 30.78%	57,124 Common Stock
Oct 13 2023	SELL Sale (or disposition) back to the issuer	$5,668 $4.04 p/Share	1,403 Reduced 3.66%	36,969 Common Stock
Jul 18 2023	BUY Grant, award, or other acquisition	-	2,571 Added 6.28%	38,372 Common Stock
Mar 16 2023	SELL Payment of exercise price or tax liability	$32,310 $8.27 p/Share	3,907 Reduced 9.84%	35,801 Common Stock
Mar 16 2023	BUY Exercise of conversion of derivative security	-	13,750 Added 25.72%	39,708 Common Stock
Dec 27 2022	SELL Payment of exercise price or tax liability	$2,699 $9.44 p/Share	286 Reduced 1.09%	25,958 Common Stock
Dec 27 2022	BUY Exercise of conversion of derivative security	-	1,150 Added 4.2%	26,244 Common Stock
Jul 19 2022	SELL Sale (or disposition) back to the issuer	$5,519 $8.4 p/Share	657 Reduced 2.55%	25,094 Common Stock
Jul 18 2022	BUY Grant, award, or other acquisition	-	2,571 Added 10.15%	22,751 Common Stock
Mar 16 2022	SELL Payment of exercise price or tax liability	$22,077 $7.97 p/Share	2,770 Reduced 12.07%	20,180 Common Stock
Mar 16 2022	BUY Exercise of conversion of derivative security	-	11,000 Added 32.4%	22,950 Common Stock
Feb 15 2022	SELL Payment of exercise price or tax liability	$3,368 $8.42 p/Share	400 Reduced 3.24%	11,950 Common Stock
Feb 15 2022	BUY Grant, award, or other acquisition	-	1,325 Added 9.69%	12,350 Common Stock
Dec 27 2021	SELL Payment of exercise price or tax liability	$2,786 $9.74 p/Share	286 Reduced 2.54%	10,984 Common Stock
Dec 27 2021	BUY Exercise of conversion of derivative security	-	1,150 Added 9.26%	11,270 Common Stock
Jul 20 2021	SELL Payment of exercise price or tax liability	$12,230 $19.2 p/Share	637 Reduced 5.92%	10,120 Common Stock
Jul 19 2021	BUY Grant, award, or other acquisition	-	2,572 Added 19.3%	10,757 Common Stock
Feb 17 2021	SELL Payment of exercise price or tax liability	$7,596 $18.71 p/Share	406 Reduced 5.45%	7,046 Common Stock
Feb 16 2021	BUY Grant, award, or other acquisition	-	1,325 Added 15.1%	7,452 Common Stock
Dec 29 2020	SELL Open market or private sale	$10,098 $17.81 p/Share	567 Reduced 9.3%	5,529 Common Stock
Dec 27 2020	BUY Grant, award, or other acquisition	-	2,300 Added 27.39%	6,096 Common Stock

Angelo Scopelianos

Chief R&D Officer

Alachua, FL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AXGN shares.

Notify only if

Value

Insider Trading

Get notified when an Axogen, Inc. insider buys or sells AXGN shares.

Notify only if

Operation

Value

Type

News

Receive news related to Axogen, Inc.

Track Activities on AXGN

Account